1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Globally, the prevalence of CVDs is steadily increasing. CVDs are estimated caused to approximately 19 million death globally by 2021. The prevalence of CVDs increases significantly with the age. According to World Bank grownup, the population aged 65 years and above increased from 7.64% in 2010 to 8.7%in 2017 globally. These factors are expected to raise the demand for cardiac implants which in turn drive the market growth. According to industry experts, the slit lamps market, will grow at a CAGR of about 4% during the forecast period.
Market Overview
Increasing prevalence of CVDs
The prevalence of CVDs in increasing which dependent on the age. Furthermore, the associated risk factor of CVDs such as blood pressure, obesity, smoking and alcohol consumption are also on the rise. Such factors propelled the demand for cardiac implants.
High cost of cardiac implants and implantation procedures
Vendors offering implantable devices can maintain high prices are part due to structural barriers to competition such as complex, cost regulatory approval process, and patient protection. Therefore, the high cost of cardiac implants and procedures is hampering the growth of the market during our forecast period.
For the detailed list of factors that will drive and challenge the growth of the cardiac implants market during the 2018-2022, view this report.
Competitive Landscape
The cardiac implants market is highly concentrated with the presence of a few cardiac implant manufacturers. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Market Overview
Increasing prevalence of CVDs
The prevalence of CVDs in increasing which dependent on the age. Furthermore, the associated risk factor of CVDs such as blood pressure, obesity, smoking and alcohol consumption are also on the rise. Such factors propelled the demand for cardiac implants.
High cost of cardiac implants and implantation procedures
Vendors offering implantable devices can maintain high prices are part due to structural barriers to competition such as complex, cost regulatory approval process, and patient protection. Therefore, the high cost of cardiac implants and procedures is hampering the growth of the market during our forecast period.
For the detailed list of factors that will drive and challenge the growth of the cardiac implants market during the 2018-2022, view this report.
Competitive Landscape
The cardiac implants market is highly concentrated with the presence of a few cardiac implant manufacturers. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 08: CUSTOMER LANDSCAPEPART 11: DECISION FRAMEWORK
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 09: MARKET SEGMENTATION BY END-USER
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
Global Cardiac Implants Market 2018-2022
The analyst recognizes the following companies as the key players in the global cardiac implants market: Abbott, BIOTRONIK, Boston Scientific, Medtronic.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the vendors are increasingly focus in their R&D efforts for the development of innovative cardiac impacts.”
According to the report, one of the major drivers for this market is the growing awareness initiatives and access to healthcare.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of cardiac implants and implantation procedures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global cardiac implants market: Abbott, BIOTRONIK, Boston Scientific, Medtronic.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the vendors are increasingly focus in their R&D efforts for the development of innovative cardiac impacts.”
According to the report, one of the major drivers for this market is the growing awareness initiatives and access to healthcare.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of cardiac implants and implantation procedures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
Note: Product cover images may vary from those shown
